Out of all the biomarkers associated with cell proliferation, Ki-67 is the most suitable candidate for breast cancer research because it is expressed in almost all normal and malignant cells and it is an easy and reliable method of assessing the cell cycle pathways. This evidence concerns the gene MKI67 and breast cancer.